Vol 8, No 1 (2011)

Articles
Epidemiya ozhireniya: ochevidnye i veroyatnye prichiny
.
Abstract
Obesity and obesity-related disorders, such as type 2 diabetes, has become a global epidemic. Although there is abundant evidence that diet and exercise are key factors in the obesity epidemic, it is equally clear that a variety of environmental factors play an important role in this process. These include such factors as gut flora, insufficient sleep, stress, social environment, maternal influences, endocrine disrupters and others. These factors target key hormonal signaling pathways involved in adipogenesis, regulation of appetite. They are also likely to play important roles in obesity epidemic and are therefore worthy of further study.
Obesity and metabolism. 2011;8(1):5-19
views
Aktivnost' renin-angiotenzinovoy sistemy (RAS) zhirovoy tkani: metabolicheskie effekty blokady RAS
.
Abstract
The review presents data confirming that fat tissue is a significant source of synthesis of all components of renin-angiotensin system (RAS). It is proposed that activation of fat tissue RAS components have a local paracrine and autocrine actions on adipocytes, regulates their growth and differentiation, induces subclinical inflammation and insulin resistance (IR). Thus, hyperactivity of local RAS in fat tissue is one of the mechanisms of visceral obesity, IR and metabolic syndrome. Use of traditional RAS blocking medications (angiotensin converting enzyme inhibitors, angiotensin receptor blockers) is followed by IR decrease and prevents from development of type 2 diabetes mellitus. The perspectives of use of a new RAS blocker from a group of direct rennin inhibitors - aliskiren - for correction of metabolic abnormalities in visceral obesity are considered.
Obesity and metabolism. 2011;8(1):21-25
views
Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh
Pigarova E.A., Dzeranova L.K.
Abstract

Octreotide is a synthetic analog of hypothalamic hormone somatostatin. This neuropeptide is widely distributed in humans and animals in central nervous system and periphery, which defines its potential regulatory functions. In 1987 the first registration was received for octreotide preparation, Sandostatin, for treatment of acromegaly and carcinoid tumors. In 1997 a long lasting form of octreotide appeared - Sandostatin LAR. At the present time both preparations have found their use in multiple areas of medicine for treatment of different metabolic, neuroendocrine and oncologic diseases.

Obesity and metabolism. 2011;8(1):26-30
views
Adipotsitokiny v nauchnoy i klinicheskoy praktike
.
Abstract
In recent decades, overweight and obesity have become a major problem for most countries. According to the World Health Organization (WHO), more than a billion people worldwide are overweight and more than 300 million are obese. These clinical and experimental studies highlight a clear relationship between obesity and several chronic diseases such as type 2 diabetes mellitus (T2DM), atherosclerosis, coronary heart disease, high risk of oncological diseases, disorders of the reproductive sphere, pathology of the musculoskeletal system, as well as deviations in mental status and processes of social adaptation. Therefore, considerable efforts of modern endocrinology focused on the study of etiopathogenetic aspects that underlie these diseases and identification of possible markers.
Obesity and metabolism. 2011;8(1):32-39
views
Potentsial'nye vozmozhnosti metformina v profilaktike i lechenii onkologicheskikh zabolevaniy u bol'nykh sakharnym diabetom 2 tipa
., ., .
Abstract
Diabetes mellitus is associated with increased risk of several types of cancer, and also with increased cancer mortality. Chronic hyperinsulinemia plays the main pathogenetic role in this association, which is mediated by a number of molecular mechanisms, described in this issue. Drugs that increase insulin sensitivity and reduce hyperinsulinemia (metformin in the first place) display anticancer effect. Aside from the anticancer effect, mediated by reduction of insulin resistance, metformin may directly suppress cancer cells growth and proliferation via stimulation of AMP kinase (AMPK). Antiproliferative action of metformin in breast and ovarian cancer is confirmed in a number of experimental and clinical trials. Its found out that therapeutic effect of metformin in treatment of breast cancer depends on the presence/absence of some molecular features of the tumor (for example, increased expression of HER2 and/or activation of p70S6K1). In order to specify mechanisms of action and effects of metformin in oncological practice several trials are being conducted or planned, most of all, in all subtypes of breast cancer. Confirmation of the anticancer effectiveness of metformin will promote an expansion of its use in clinical practice and in clinical oncology, particularly.
Obesity and metabolism. 2011;8(1):40-49
views
Sovremennaya kontseptsiya lecheniya ozhireniya
.
Abstract
Obesity is an unsolved problem of modern society, furthermore it is one of the main risk factors for type 2 diabetes mellitus, cardiovascular diseases and cancer, pathology of musculoskeletal and digestive systems, reproductive disfunction both for women and for men. It is known that treatment any chronic disease is rather complicated, not only for doctors but also for the patient, because it requires from the patient a careful self-control and substantial changes in lifestyle. In modern clinical practice, various methods of treatment of obesity are used: diet therapy, exercise therapy, physiotherapy, pharmacotherapy, psychotherapy and surgery. Modern methods of treatments of obesity are reviewed in this article
Obesity and metabolism. 2011;8(1):51-56
views
Problemy lecheniya patsientov s morbidnym ozhireniem
.
Abstract
The article describes evidence-based approaches to treatment of morbid obesity, including surgical interventions designated for bodyweight reduction and provides comparative analysis of efficacy and safety of lifestyle interventions, medical treatment and various types of bariatric surgery. Detailed description of diagnosis, treatment and prevention of post-surgical vitamin and mineral deficiencies is given. Special attention is paid to high prevalence of mental disorders in patients with morbid obesity, their role in its development, their influence on outcomes of surgical intervention and potential patient dissatisfaction with its results. Necessity of thorough selection of patients for bariatric surgery is emphasized, with assessment of their mental state and proper organization of subsequent life-long follow-up after operation
Obesity and metabolism. 2011;8(1):57-66
views
Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis
., ., ., .
Abstract
Obesity and metabolism. 2011;8(1):67-68
views
Associations between gender, age and waist circumference
., ., .
Abstract
Obesity and metabolism. 2011;8(1):68-69
views
Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk
., ., ., ., .
Abstract
Obesity and metabolism. 2011;8(1):69-69
views
Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea
.
Abstract
Obesity and metabolism. 2011;8(1):70-70
views
Maternal body mass index and congenital anomaly risk: a cohort stu
., ., ., ., ., .
Abstract
Obesity and metabolism. 2011;8(1):71
views
Weight loss from maximum body weight and mortality: the Third National Health and Nutrition Examination Survey LinkedMortality File
., .
Abstract
Obesity and metabolism. 2011;8(1):70
views
Expanding the definition of hypothalamic obesity
., .
Abstract
Obesity and metabolism. 2011;8(1):72-73
views
Konferentsii po problemam endokrinologii, ozhireniya i metabolizma v 2011 godu
.
Abstract
Obesity and metabolism. 2011;8(1):74-75
views
Sochetanie uluchsheniya kontrolya glikemii i snizheniya massy tela s minimal'nym riskom gipoglikemiy - nedostizhimaya tsel' vchera, real'nost' segodnya
.
Abstract
Obesity and metabolism. 2011;8(1):76-79
views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies